Background illustration for clinical trials search

Paid Clinical Trials Los Angeles

Discover 3,549 paid clinical trials in Los Angeles, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

for
Glioma, Astrocytoma, Grade IV, IDH1-mutant Glioma,
Location: Los Angeles CA, Newport Beach CA, La Jolla CA,
Sponsor: Nuvation Bio Inc.

Sex: All

Age: 18+

Code: NCT05303519

Phase3, Recruiting
Active & Responsive

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

for
Breast Neoplasms, Colorectal Neoplasms, Prostate Neoplasm,
Location: Santa Monica CA, Duarte CA, Stanford CA, Houston TX,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07114601

Phase1, Recruiting
Active & Responsive

Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy

for
LAMA2-MD \(Merosin Deficient Congenital Muscular Dystrophy, MDC1A\),
Location: Los Angeles CA, Stanford CA, Dallas TX, Saint Paul MN,
Sponsor: Nationwide Children's Hospital

Sex: All

Age: 0 - 5

Code: NCT06503367

Recruiting
Active & Responsive

DMCRN-02-001: Assessing Pediatric Endpoints in DM1

for
Congenital Myotonic Dystrophy, CDM
Location: Los Angeles CA, Fairway KS, Rochester NY, Richmond VA
Sponsor: Virginia Commonwealth University

Sex: All

Age: 0 - 4

Code: NCT05224778

Recruiting
Active & Responsive

Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease

for
Systemic Lupus Erythematosus
Location: Los Angeles CA, San Diego CA, Oklahoma City OK,
Sponsor: NYU Langone Health

Sex: All

Age: 55+

Code: NCT05799378

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

for
Parenteral Nutrition Associated Liver Disease (PNALD),
Location: Los Angeles CA, Fountain Valley CA, Seattle WA,
Sponsor: Fresenius Kabi

Sex: All

Age: 0 - 17

Code: NCT06274788

Recruiting
Active & Responsive

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

for
Colorectal Cancer, Pancreatic Ductal Adenocarcinoma,
Location: Los Angeles CA, Aurora CO, Houston TX, Madison WI,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06428409

Phase1, Phase2, Recruiting
Active & Responsive

A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)

for
PIK3CA-Related Overgrowth Spectrum (PROS),
Location: Los Angeles CA, Palo Alto CA, San Francisco CA,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 2+

Code: NCT06789913

Phase2, Recruiting
Active & Responsive

Motivation for IV Alcohol Self-Administration in Humans

for
Alcohol Use Disorder
Location: Los Angeles CA
Sponsor: University of California, Los Angeles

Sex: All

Age: 21 - 65

Code: NCT06494891

Phase2, Recruiting
Active & Responsive

A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

for
Age-Related Macular Degeneration
Location: Los Angeles CA, Riverside CA, Palo Alto CA, Portland OR,
Sponsor: Astellas Institute for Regenerative Medicine

Sex: All

Age: 50+

Code: NCT03178149

Phase1, Recruiting
Active & Responsive

Randomized Controlled Trial of the STEIN Protocol: A Neuroplastic Pain Education and Guided Breathing Intervention During Awake Cataract Surgery

for
Cataract, Cataract (Post-operative Cataract Surgery Follow-up)
Location: Los Angeles CA
Sponsor: University of California, Los Angeles

Sex: All

Age: 0+

Code: NCT07715591

Recruiting
Active & Responsive

Personalized Brain Stimulation to Treat Chronic Concussive Symptoms

for
Post-Concussion Syndrome, Concussion, Brain,
Location: Westwood, Los Angeles CA
Sponsor: University of California, Los Angeles

Sex: All

Age: 18 - 65

Code: NCT06073886

Phase2, Recruiting
Active & Responsive

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Los Angeles CA, La Jolla CA, Stanford CA,
Sponsor: Bicara Therapeutics

Sex: All

Age: 18+

Code: NCT06788990

Phase2, Phase3, Recruiting
Active & Responsive

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

for
Myelofibrosis; Anemia, Anemia, Myelofibrosis,
Location: Los Angeles CA, Duarte CA, Irvine CA, San Francisco CA,
Sponsor: Disc Medicine, Inc

Sex: All

Age: 18+

Code: NCT05320198

Phase1, Phase2, Recruiting
Active & Responsive

Women Informed to Screen Depending on Measures of Risk (Wisdom Study)

for
Breast Cancer Screening, Breast Carcinoma in Situ,
Location: Los Angeles CA, Irvine CA, San Diego CA,
Sponsor: University of California, San Francisco

Sex: Female

Age: 30 - 70+

Code: NCT02620852

Recruiting
Active & ResponsiveNew

Vorasidenib Study in Pediatric Participants With Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation

for
Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation,
Location: Los Angeles CA, Minneapolis MN, Chicago IL, Boston MA
Sponsor: Institut de Recherches Internationales Servier (I.R.I.S.)

Sex: All

Age: 12 - 17

Code: NCT07286292

Phase2, Recruiting
Active & Responsive

Impact of Prebiotics in Ulcerative Colitis

for
Crohn Disease, Ulcerative Colitis
Location: Los Angeles CA
Sponsor: University of California, Los Angeles

Sex: All

Age: 18 - 70+

Code: NCT06495658

Recruiting
Active & Responsive

BBD Longitudinal Study of Osteogenesis Imperfecta

for
Osteogenesis Imperfecta
Location: Los Angeles CA, Phoenix AZ, Portland OR, Omaha NE,
Sponsor: Baylor College of Medicine

Sex: All

Age: 0+

Code: NCT02432625

Recruiting
Active & Responsive

Diagnostic Performance Study of the EMVision Emu™ Brain Scanner in the Detection of Intracranial Hemorrhage in Suspected Stroke Patients

for
Stroke, Hemorrhagic Stroke
Location: Los Angeles CA, Houston TX, Jacksonville FL,
Sponsor: EMVision Medical Devices Ltd

Sex: All

Age: 22+

Code: NCT06999122

Recruiting
Active & Responsive

Human Laboratory Study of Apremilast for Alcohol Use Disorder

for
Alcohol Use Disorder, Alcohol Misuse
Location: Los Angeles CA, Aurora CO, Charlottesville VA
Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Sex: All

Age: 21+

Code: NCT07325266

Phase2, Recruiting

With a vast healthcare network and top-tier medical research centers, Los Angeles is a key hub for a wide range of clinical trials. Renowned institutions such as UCLA Health, Cedars-Sinai Medical Center, and the Keck School of Medicine at USC lead pioneering research across various fields, including cancer, cardiovascular health, and neuroscience.

Many Los Angeles medical centers are at the forefront of innovative studies, positioning the city as a critical location for advancing medical research and improving patient care outcomes.

Why choose Los Angeles for clinical trials?

Los Angeles offers distinct advantages for individuals participating in clinical trials. The city’s diverse population provides a wide range of participants, enhancing the accuracy and applicability of research findings across different demographics.

Known for its forward-thinking research environment, Los Angeles is home to leading institutions that drive cutting-edge studies in a variety of medical fields. By choosing to participate in a clinical trial in Los Angeles, individuals contribute to groundbreaking medical research while benefiting from the city's well-established clinical research infrastructure and access to world-class healthcare professionals.

Common conditions studied in Los Angeles

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Los Angeles